K. Morimoto

Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain

Keiichi Tanaka, K. Morimoto, A. Miura, 2017, Inflammation Research.

An anti-rheumatic agent T-614 inhibits NF-κB activation in LPS- and TNF-α-stimulated THP-1 cells without interfering with IκBα degradation

K. Tanaka, T. Yamamoto, Y. Aikawa, 2002, Inflammation Research.

Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1

S. Hirono, Tetsuya Yamamoto, A. Hashiramoto, 2008, Nature Biotechnology.

An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation.

T. Yamamoto, Y. Aikawa, K. Tanaka, 2002, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain

Keiichi Tanaka, K. Morimoto, A. Miura, 2017, Inflammation Research.